Topp L - Search Results

1

The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature.

Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. Islam MM, et al. Among authors: topp l. Int J Drug Policy. 2012 Mar;23(2):94-102. doi: 10.1016/j.drugpo.2011.08.005. Epub 2011 Oct 12. Int J Drug Policy. 2012. PMID: 21996165 Review.

2

The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System.

Darke S, Topp L, Ross J. Darke S, et al. Among authors: topp l. Drug Alcohol Rev. 2002 Mar;21(1):27-32. doi: 10.1080/09595230220119318. Drug Alcohol Rev. 2002. PMID: 12189001

3

Decreased heroin availability in Sydney in early 2001.

Day C, Topp L, Rouen D, Darke S, Hall W, Dolan K. Day C, et al. Among authors: topp l. Addiction. 2003 Jan;98(1):93-5. doi: 10.1046/j.1360-0443.2003.00266.x. Addiction. 2003. PMID: 12492759

4

Contemplating drug monitoring systems in the light of Australia's "heroin shortage".

Topp L, Degenhardt L, Day C, Collins L. Topp L, et al. Drug Alcohol Rev. 2003 Mar;22(1):3-6. doi: 10.1080/0959523021000059767. Drug Alcohol Rev. 2003. PMID: 12745352 No abstract available.

5

Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia.

Topp L, Day C, Degenhardt L. Topp L, et al. Drug Alcohol Depend. 2003 Jun 5;70(3):275-86. doi: 10.1016/s0376-8716(03)00013-9. Drug Alcohol Depend. 2003. PMID: 12757965

6

Safety in drug and alcohol research.

Day C, Topp L. Day C, et al. Among authors: topp l. Addiction. 2003 Dec;98(12):1641-3. doi: 10.1111/j.1360-0443.2003.00486.x. Addiction. 2003. PMID: 14651490 No abstract available.

7

Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey.

Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L; Collaboration of Australian Needle Syringe Programs. Topp L, et al. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):632-8. doi: 10.1097/qai.0b013e31816a1d68. J Acquir Immune Defic Syndr. 2008. PMID: 18491422

8

Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.

Day CA, Topp L, Iversen J, Maher L; Collaboration of Australian NSPs. Day CA, et al. Among authors: topp l. Drug Alcohol Rev. 2008 Sep;27(5):559-61. doi: 10.1080/09595230801956132. Drug Alcohol Rev. 2008. PMID: 18608447 No abstract available.

9

GHB in Sydney, Australia, 2000-2006: a case study of the EDRS as a strategic early warning system.

Dunn M, Topp L, Degenhardt L. Dunn M, et al. Among authors: topp l. Int J Drug Policy. 2009 Sep;20(5):413-7. doi: 10.1016/j.drugpo.2009.01.002. Epub 2009 Feb 23. Int J Drug Policy. 2009. PMID: 19237274

10

Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study.

Doab A, Topp L, Day CA, Dore GJ, Maher L. Doab A, et al. Among authors: topp l. Contemp Clin Trials. 2009 Sep;30(5):431-5. doi: 10.1016/j.cct.2009.04.002. Epub 2009 Apr 16. Contemp Clin Trials. 2009. PMID: 19376270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters